Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026

Impact · against what's priced in

Spyre Therapeutics is introducing the first public clinical data for its three IBD antibodies and additive preclinical data for combinations. This represents a material catalyst as it transitions the pipeline from private internal data to public scientific validation.

SYRE+0.60: No priced-in read yet

Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026

What matters in this story

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.

Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026

What matters in this story

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.

How each ticker is affected

Track these names every morning.

ARDX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Ardelyx (ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026

Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.

Oruka Therapeutics: The Psoriasis Market Is Becoming A Barbell, And ORKA-001 Owns The Far End

SNDX Investors with $100,000 in Losses Have Opportunity to Join Syndax Pharmaceuticals, Inc. Fraud Investigation with SBS Law

Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026

What matters in this story

Next reads from the same story arc

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.

Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026

What matters in this story

Next reads from the same story arc

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.

How each ticker is affected

Track these names every morning.

ARDX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Ardelyx (ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026

Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.

Oruka Therapeutics: The Psoriasis Market Is Becoming A Barbell, And ORKA-001 Owns The Far End

SNDX Investors with $100,000 in Losses Have Opportunity to Join Syndax Pharmaceuticals, Inc. Fraud Investigation with SBS Law